home
|
sitemap
Spherix D-Tagatose To Be Supplied By Inalco S.P.A.
more»
Spherix CEO, Dr. Claire Kruger, Quoted at Recent International Probiotics Association Conference.
NutraUSA»
FoodUSA»
Spherix Hires Renowned Toxicologist, Dr. Andrew Wallace Hayes, as Principal Advisor.
more»
||
View All
||
Innovative biotechnology solutions for nutrition and health.
Learn more»
Expert support through the lifecycle of our clients' products.
Learn more»
Naturlose® (tagatose) is currently undergoing testing in a phase 3 clinical trial as a treatment for Type 2 diabetes.
Learn more»
Copyright©2007 Spherix | All rights reserved
About
|
Investors
|
Media Center
|
Careers
|
Contact
|
Privacy
|
Terms
